Organoid test to guide osteosarcoma treatment
Part of Cancer clinical trials.
This trial uses a lab-grown mini tumor (organoid) from your biopsy to test which drugs might work best for your osteosarcoma. It aims to personalize your treatment based on how your specific cancer cells respond.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have imaging that suggests osteosarcoma and are scheduled for a biopsy or surgery to confirm it.
- Your imaging suggests the cancer may have spread (metastatic) and you are scheduled for a biopsy or surgery.
- You are willing to have a small piece of your tumor used to grow an organoid in the lab for drug testing.
- You have not yet started treatment for this cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the genetic makeup of your osteosarcoma (a bone cancer) to try to understand its immune environment. The goal is to find more personalized treatments based on your tumor's specific features.
This trial tests a new drug called OMO-103, which targets a protein called Myc that helps cancer cells grow. It is for people with advanced osteosarcoma (bone cancer) that has worsened after standard chemotherapy. The drug is given intravenously (through a vein), and the study will check if it is safe and shrinks tumors.
This trial tests a special dye that targets B7-H3, a protein found on osteosarcoma cells. Before your surgery, the dye is injected and helps surgeons see tumor edges more clearly, so they can remove all of the cancer while saving healthy tissue.
This study looks at the experiences of people with osteosarcoma who are taking part in clinical trials. By joining, you'll help researchers understand what it's like for patients, which may improve future care.
This trial focuses on improving how osteosarcoma care is coordinated and delivered, using collaboration between clinicians. It may help by helping teams make more consistent treatment decisions for people newly diagnosed.
This trial uses a lab-grown mini-tumor (organoid) from your biopsy to test which chemotherapy drugs work best for your cancer before you have surgery. The goal is to personalize your treatment and improve outcomes.
Hear when a new Osteosarcoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.